Cited by 798Heart Failure Treatment and ManagementCardiovascular Function and Risk FactorsHeart rate and cardiovascular health

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-Year Follow-Up Outcomes and Differences Across Regions

Open access

Crespo-Leiro, Maria G., Anker, Stefan D., Maggioni, Aldo P., Coats, Andrew J., Filippatos, Gerasimos, Ruschitzka, Frank, Ferrari, Roberto, Piepoli, Massimo Francesco, Delgado Jimenez, Juan F., Metra, Marco, Fonseca, Candida, Hradec, Jaromir, Amir, Offer, Logeart, Damien, Dahlström, Ulf, Merkely, Bela, Drozdz, Jaroslaw, Goncalvesova, Eva, Hassanein, Mahmoud, Chioncel, Ovidiu, Lainscak, Mitja, Seferovic, Petar M., Tousoulis, Dimitris, Kavoliuniene, Ausra, Fruhwald, Friedrich, Fazlibegovic, Emir, Temizhan, Ahmet, Gatzov, Plamen, Erglis, Andrejs, Laroche, Cécile, Mebazaa, Alexandre·2016·European Journal of Heart Failure

DOI 10.1002/ejhf.566

Open this paper in CoChat — free account Open PDF

Abstract

Aims: The European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT-R) was set up with the aim of describing the clinical epidemiology and the 1-year outcomes of patients with heart failure (HF) with the added intention of comparing differences between participating countries. Methods and results: The ESC-HF-LT-R is a prospective, observational registry contributed to by 211 cardiology centres in 21 European and/or Mediterranean countries, all being member countries of the ESC. Between May 2011 and April 2013 it collected data on 12 440 patients, 40.5% of them hospitalized with acute HF (AHF) and 59.5% outpatients with chronic HF (CHF). The all-cause 1-year mortality rate was 23.6% for AHF and 6.4% for CHF. The combined endpoint of mortality or HF hospitalization within 1 year had a rate of 36% for AHF and 14.5% for CHF. All-cause mortality rates in the different regions ranged from 21.6% to 36.5% in patients with AHF, and from 6.9% to 15.6% in those with CHF. These differences in mortality between regions are thought reflect differences in the characteristics and/or management of these patients. Conclusion: The ESC-HF-LT-R shows that 1-year all-cause mortality of patients with AHF is still high while the mortality of CHF is lower. This registry provides the opportunity to evaluate the management and outcomes of patients with HF and identify areas for improvement.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/ejhf.566

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
Self-citation
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs105 · Cited by 2,644
Self-citation
The Global Health and Economic Burden of Hospitalizations for Heart Failure
Ambrosy, A. P., Fonarow, G. C., Butler, J., Chioncel, O. D., Greene, S. J., Vaduganathan, M., Nodari, S., Lam, C. S. P., Sato, N., Shah, A. N., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.053 · Cited by 2,110
Self-citation
Heart Failure: Preventing Disease and Death Worldwide
Ponikowski, P. P., Anker, S. D., AlHabib, K. F., Cowie, M., Force, T. L., Hu, S., Jaarsma, T., Krum, H., Rastogi, V., Rohde, L. E. P., et al. (2014) · ESC Heart Failure · doi:10.1002/ehf2.12005 · Cited by 1,777
Self-citation
EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population
Nieminen, M. S., Brutsaert, D. L., Dickstein, K., Drexler, H., Folláth, F., Harjola, V., Hochadel, M., Michel Komajda, N., Lassus, J. P. E., Lopez-Sendon, J. L., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl193 · Cited by 1,292
The EuroHeart Failure Survey programme—a survey on the quality of care among patients with heart failure in Europe Part 2: treatment
Michel Komajda, N. (2003) · European Heart Journal · doi:10.1016/s0195-668x(02)00700-5 · Cited by 1,219
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure
Nieminen, M. S., Böhm, M., Cowie, M., Drexler, H., Filippatos, G. S., Jondeau, G., Hasin, Y., Lopez-Sendon, J., Mebazaa, A., Metra, M., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi044 · Cited by 1,173
Self-citation
EUR Observational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)
Maggioni, A. P., Dahlström, U., Filippatos, G. S., Chioncel, O., Leiro, M. C., Dróżdż, J., Fruhwald, F. M., Gullestad, L. L., Logeart, D., Fabbri, G., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft050 · Cited by 804
Self-citation
Are Hospitalized or Ambulatory Patients with Heart Failure Treated in Accordance with European Society of Cardiology Guidelines? Evidence from 12 440 Patients of the ESC Heart Failure Long-Term Registry
Maggioni, A. P., Anker, S. D., Dahlström, U., Filippatos, G. S., Ponikowski, P. P., Zannad, F. M., Amir, O., Chioncel, O., Crespo‐Leiro, M. G., Dróżdż, J., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft134 · Cited by 666
Self-citation

Show all 26 references

Sorted by citations

Items 501–600 of 793

Biological and chronological age in heart failure
Lainščak, M., & Vitale, C. (2016) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000448 · Cited by 4
Application of competing risks analysis improved prognostic assessment of patients with decompensated chronic heart failure and reduced left ventricular ejection fraction
Scrutinio, D., Guida, P., Passantino, A., Ammirati, E., Oliva, F. G., Lagioia, R., & Frigerio, M. (2018) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2018.07.006 · Cited by 4
Nuevos enfoques en el tratamiento de la insuficiencia cardiaca: un cambio en la estrategia terapéutica
Obaya, J. C. (2022) · Atención Primaria · doi:10.1016/j.aprim.2022.102309 · Cited by 4
Impact of chronic renin-angiotensin-aldosterone inhibitors on short-term outcomes in patients with acute heart failure presenting to the emergency department. A propensity-matched analysis EAHFE cohort
Haro, A., Jacob, J., Rosselló, X., Llorens, P., Herrero, P., Alquézar‐Arbé, A., Llauger, L., Aguirre, A., Piñera, P., Espinosa, B., et al. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132615 · Cited by 3
An Individual Treatment Effect Approach to Predict Response to Mineralocorticoid Receptor Antagonists in Patients with Heart Failure and Reduced Ejection Fraction
Kobayashi, M., Duarte, K., Ferreira, J. P., Baudry, G., Monzo, L., McMurray, J. J. V., van Veldhuisen, D. J., Pitt, B., Zannad, F. M., & Girerd, N. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.70047 · Cited by 3
Heart failure in Kenya: epidemiology, management patterns, and outcomes from a national multicenter registry
Varwani, M. H., Kassam, N., Shah, J., Barasa, A. L., & Ngunga, M. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-05158-w · Cited by 3
“This aligns with data from the THESUS-HF [10] and INTER-CHF [11] registries, as well as European studies such as the ESC-HF [24] Long-Term Registry and the Euro Heart Failure Survey.”
Early initiation of SGLT2 inhibitors within guideline-directed medical therapy and outcomes in newly diagnosed heart failure patients
Esteban‐Fernández, A., López‐Fernández, S., Pastor‐Pérez, F. J., Pérez-Rivera, J.-Á., Bonilla‐Palomas, J. L., Cobo-Marcos, M., García‐Pinilla, J. M., Bonet, L. A., Fluvià-Brugués, P., Bermúdez-Jiménez, F. J., et al. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-05316-0 · Cited by 3
“European data indicate that within one year, about 36% of acute HF patients and 14.5% of chronic HF patients experience either mortality or hospitalization [1].”
Influential
Therapeutic Advances in the Management of Cardiogenic Shock
Filipescu, R., Collins, S. P., Radu, R. I., Gal, T. B., Antohi, E., Abdelhamid, M., Geavlete, O. D., Pană, M.-A., Farmakis, D. T., Matei, D.-C., et al. (2026) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000002025 · Cited by 3
Self-citation
Prognostic Role of High-Sensitivity C-Reactive Protein/Albumin Ratio in Heart Failure Patients
Martire, D., Armentaro, G., Severini, G., Pastura, C. A., Scarcelli, M. R., Cassano, V., Crasà, M., Gareri, I., Cortese, G., Condoleo, V., et al. (2026) · Biomedicines · doi:10.3390/biomedicines14040748 · Cited by 3
Contemporary Management of Acute Heart Failure
Bruno, J., Arrigo, M., Baudry, G., Biegus, J., Bozkurt, B., Čerlinskaitė‐Bajorė, K., COHEN, L. P., Hartshorne‐Evans, N., Ishihara, S., Jessen, N., et al. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.03.029 · Cited by 3
Self-citation
Prognostic Factors of Readmission and Mortality After First Heart Failure Hospitalization: Results from EPICAL2 Cohort
Varlot, J., Popovic, B., Soudant, M., Thilly, N., & Agrinier, N. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14246 · Cited by 2
“14246 admissions24,25 and mortality.11,12 Due to the huge prognostic burden of comorbidities in HF patients whatever the final state considered, a holistic management programme including therapeutic education and management of both cardiovascular and non-cardiovascular conditions seems critical to improve HF prognosis…”
Influential
Evaluating initiation and real-world tolerability of dapagliflozin for the management of HFrEF
Tee, A. H. L., Campbell, G., & D’Silva, A. (2023) · British Journal of Cardiology · doi:10.5837/bjc.2023.002 · Cited by 3
New insights in acute heart failure
Asakage, A., Mebazaa, A., & Deniau, B. (2023) · La Presse Médicale · doi:10.1016/j.lpm.2023.104184 · Cited by 3
Self-citation
Analysis of the Larissa Heart Failure Risk Score: Predictive Value in 9207 Patients Hospitalized for Heart Failure from a Single Center
Xanthopoulos, A. V., Skoularigis, J. S., Briasoulis, Α., Magouliotis, D. E., Zajichek, A., Milinovich, A., Kattan, M. W., Triposkiadis, F. K., & Starling, R. C. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13121721 · Cited by 3
The fraction we know: heart failure phenotypes and their clinical outcomes
Kamsani, S. H., & Sanders, P. (2023) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16630 · Cited by 3
A cost-effectiveness analysis of empagliflozin for heart failure patients across the full spectrum of ejection fraction in Spain: combined results of the EMPEROR-Preserved and EMPEROR-Reduced trials
García–Moll, X., Croci, F., Solé, A., Hartgers-Gubbels, E. S., & Calleja‐Hernández, M. Á. (2024) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2024.2324027 · Cited by 3
“In Spain, HF is the leading cause of hospitalization in patients above 65 years old [8].”
Background
Epidemiology and mortality due to heart failure
Fedačko, J., Tuppo, E. E., Singh, R. B., Elkilany, G. N., & Hristová, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-822972-9.00017-1 · Cited by 3
Reassessing heart failure therapy in Thailand: Patient insights and treatment outcomes from the Thai heart failure registry
Krittayaphong, R., Yingchoncharoen, T., Puwanant, S., Boonyapiphat, T., Charoenyos, N., Wongtheptien, W., Chotenimitkhun, R., Chichareon, P., Phrommintikul, A., Thundee, C., et al. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132235 · Cited by 3
Assessing the predictive value of the controlling nutritional status score on all-cause mortality during hospitalization in patients with acute decompensated heart failure: a retrospective cohort study from Jiangxi, China
Huang, X., Qiu, J., Kuang, M., Wang, C., He, S., Yu, C., Xie, G., Sheng, G., & Zou, Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1392268 · Cited by 3
Clinical profile, treatment patterns and one-year outcome of heart failure patients admitted in tertiary care hospital of North India
Shah, U. A., Rashid, A., Mufti, S. A., Khan, S., Qazi, Z. M., Masoom, I., Khuja, Z., Bukhari, I., Kakroo, S. A., & Rather, H. (2024) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1868_23 · Cited by 3
“[16,21] The lower incidence of HFPEF in our populations compared with the West can be explained by the fact that in the West, risk factors for CAD such as DM, tobacco consumption, and hypertension have been aggressively addressed, resulting in decreased incidence of HfrEF.”
BackgroundResult
Global use of angiotensin receptor neprilysin inhibitor in heart failure and reduced, below normal and supranormal ejection fraction
Horiuchi, Y., Asami, M., Yahagi, K., Oshima, A., Gonda, Y., Yoshiura, D., Komiyama, K., Yuzawa, H., Tanaka, J., Aoki, J., et al. (2024) · Heart and Vessels · doi:10.1007/s00380-024-02459-6 · Cited by 3
“Based on these results, the guidelines state that ARNI can be considered for HFmrEF or HFpEF [1, 6].”
Accurate diagnosis of heart failure and improved perioperative outcomes
Deniau, B., Léopold, V., & Mebazaa, A. (2024) · British Journal of Anaesthesia · doi:10.1016/j.bja.2024.10.003 · Cited by 3
Self-citation
Clinical Utility and Safety of Finerenone in Patients with Heart Failure: Rationale and Design of FINE Registry
Salinas, G. L. A., León, A. M., Cano, D. A., Esteban‐Fernández, A., Flórez, J. M. V., Díaz, S. D. P., Magaña, J. G., Delgado, G. D. L., Manzanares, R. G., Pérez, P. C., et al. (2025) · ESC Heart Failure · doi:10.1002/ehf2.15260 · Cited by 4
An AI‐Enabled, Patient‐Centred Digital Platform for Integrated Chronic Heart Failure Management: Architecture, Validation and Clinical Insights
Petridis, G., Karampatea, A., Bakogiannis, C., Rigas, E. S., Kondylakis, H., Berler, A., Kangelidis, K., Malamas, N., Kouroubali, A., Katehakis, D. G., et al. (2025) · Healthcare Technology Letters · doi:10.1049/htl2.70015 · Cited by 2
Real-world dapagliflozin treatment patterns in Portuguese patients with heart failure with reduced ejection fraction
Andrade, A., Gonçalves, S., Batista, A., Timóteo, A. T., Soares, A. O., Franco, F., Simões, O., Pardal, M., Almeida, M., Lopes, M., et al. (2025) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2025.08.007 · Cited by 4
ESC Heart Failure Receives its First Impact Factor
Anker, M. S., von Haehling, S., Papp, Z., & Anker, S. D. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1665 · Cited by 3
Self-citation
Bias in natriuretic peptide-guided heart failure trials: time to improve guideline adherence using alternative approaches
Stienen, S., Bhatt, A. S., Ferreira, J. P., Vaduganathan, M., Januzzi, J. L., Adams, K. F., Tardif, J., Rossignol, P., & Zannad, F. M. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-10004-6 · Cited by 3
Identifying Knowledge Gaps in Heart Failure Research Among Women Using Unsupervised machine-learning Methods
Alhussain, K., Kido, K., Dwibedi, N., LeMasters, T., Rose, D. E., Misra, R., & Sambamoorthi, U. (2021) · Future Cardiology · doi:10.2217/fca-2020-0083 · Cited by 3
Evolución del perfil clínico y pronóstico de pacientes con alta hospitalaria por insuficiencia cardíaca en las dos primeras décadas del sigloxxi. El Registro INCA-Ex
Fernandez-Berges, D. J., González-Fernández, R., Félix-Redondo, F. J., Arévalo‐Lorido, J. C., Rosa, L. Y., Hernández-González, M., Rubini, A., Montejano, M. G., Gamero, M. C., & Lozano, L. (2022) · Atención Primaria · doi:10.1016/j.aprim.2022.102357 · Cited by 3
Uso de NT-proBNP en el seguimiento ambulatorio de pacientes con insuficiencia cardiaca con fracción de eyección del ventrículo izquierdo reducida en una unidad multidisciplinaria de insuficiencia cardiaca
Valdivieso, C. G., Prato, L. E. B., Roja, Z. A. G., Rocha, P. Á., Legnani, L. F., & Ormaechea, G. (2023) · Revista Uruguaya de Medicina Interna · doi:10.26445/08.01.3 · Cited by 3
Ejection fraction at hospital admission stratifies mortality risk in HFmrEF patients aged ≥ 70 years: a retrospective analysis from a tertiary university institution
Sonaglioni, A., Lonati, C., Behring, M. T., Nicolosi, G. L., Lombardo, M., & Harari, S. A. (2023) · Aging Clinical and Experimental Research · doi:10.1007/s40520-023-02454-3 · Cited by 3
Efficacy and safety of Zhenyuan capsule in the treatment of chronic heart failure: A meta-analysis and trial sequential analysis
Zhang, Z., & Liu, J. (2023) · Medicine · doi:10.1097/md.0000000000035006 · Cited by 3
“[10] They are often combined for the treatment of CHF, and achieved certain clinical efficacy.[11] However, some patients remain uncontrolled in the context of combination drugs, and the long-term combination of these drugs increases the renal burden and gastrointestinal risks.”
Background
Patient Perception, Knowledge and Adaptation in The Management of Heart Failure: A Multicenter, Cross-Sectional, Observational, Questionnaire-Based Study: ADAPTATION HF
Murat, S. (2024) · Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology · doi:10.5543/tkda.2023.53574 · Cited by 3
How to Change the Medical History of Patients with Heart Failure and Recurrent Hospitalizations?
Andrade, F. A., Monferdini, L., & Vieira, J. L. (2023) · ABC Heart Failure & Cardiomyopathy · doi:10.36660/abchf.20230092 · Cited by 3
Differentiating sensor changes in a composite heart failure ICD monitoring index: clinical correlates and implications
Compagnucci, P., Santobuono, V. E., D’Onofrio, A., Vitulano, G., Calò, L., Bertini, M., Santini, L., Savarese, G., Lavalle, C., Viscusi, M., et al. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.10.021 · Cited by 3
Prognostic Implications and Global Perspectives of Atrial Fibrillation in Patients Hospitalized for Heart Failure
Chyou, J. Y., Tay, W. T., Tromp, J., Ouwerkerk, W., Yiu, K. H., Cleland, J. G. F., Collins, S. P., Angermann, C. E., Ertl, G., Dahlström, U., et al. (2025) · JACC Heart Failure · doi:10.1016/j.jchf.2024.11.009 · Cited by 3
Self-citation
Should Providers Prescribe Sacubitril/Valsartan Based on Trial Eligibility, Approval Indication, or Guideline Recommendations?
Ambrosy, A. P., Fudim, M., & Chioncel, O. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1555 · Cited by 3
Self-citation
Understanding Worsening Heart Failure as a Therapeutic Target: Another Step Forward?
Metra, M., Ravera, A., & Filippatos, G. S. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.866 · Cited by 3
Self-citation
Combination Drug Therapy in Heart Failure: Greater Than the Sum of its Parts
Ambrosy, A. P., & Chioncel, O. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1251 · Cited by 3
Self-citation
Hospitalisation and life support in the year before and during heart transplantation: a French national study
Cantrelle, C., Dorent, R., Legeai, C., Damy, T., Bastien, O. H., & Tuppin, P. (2018) · Open Heart · doi:10.1136/openhrt-2018-000913 · Cited by 3
“tively, for readmission for HF in the ESC-HF Long-Term Registry.(18) In the USA, 27% of patients hospitalised with”
Background
The Impact of Diabetes and Comorbidities on the Outcome of Heart Failure Patients Treated With Cardiac Resynchronization Therapy
Boriani, G. (2016) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004463 · Cited by 3
Acute Heart Failure and Biomarkers: Time also Matters, don't Relax
Pascual-Figal, D. A. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.880 · Cited by 3
Sudden Cardiac Death Following Admission for Acute Heart Failure: Adding Insult to Injury
Ambrosy, A. P., Fudim, M., & Chioncel, O. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1109 · Cited by 3
Self-citation
Comorbidities of chronic heart failure – a systemic syndrome requiring cross-specialty efforts
Doehner, W. (2018) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000606 · Cited by 3
Universal healthcare but not universal access?
Tromp, J., & Collins, S. P. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319870015 · Cited by 3
“Overall one-year mortality was 26%, which is comparable to contemporary data from the European Society of Cardiology Heart Failure Long-Term Registry.”
Result
The use of four-pillar regimen for heart failure management: results from the Jordanian Heart Failure Registry (JoHFR)
Izraiq, M., Jammal, M., Toubasi, A. A., Mari, S., AlNajafi, S., Al-Qadasi, A., Maharmeh, K. A., Almansour, M., Saleh, S., Ahmed, Y. B., et al. (2024) · PeerJ · doi:10.7717/peerj.18464 · Cited by 2
Intense Optimization of Oral Therapy Rapidly Restores Respiratory Function in Worsening Heart Failure Patients
Yaakoubi, H., Boukadida, L., Toumia, M., Caillard, A., Soltane, H. B., Jaballah, R., Trabelsi, I., Dhaoui, R., Zorgati, A., Boubaker, H., et al. (2025) · ESC Heart Failure · doi:10.1002/ehf2.15373 · Cited by 2
Self-citation
Advancements and Challenges in Acute Heart Failure Management in Korea: Initial Report and Insights from the Korean Heart Failure III Registry
Lee, H. K., Kim, E. J., Han, S. W., Park, S., Kim, H., Cho, M.-C., Ahn, H., Shin, M., Hwang, S., JEONG, J.-O., et al. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.07.023 · Cited by 2
Prognostic Value of the NT-proBNP-to-Albumin Ratio (NTAR) for In-Hospital Mortality in Chronic Heart Failure Patients
Cristescu, L., Mareş, R. G., Iancu, D.-G., Mărușteri, M., Varga, A., & Ţilea, I. (2025) · Biomedicines · doi:10.3390/biomedicines13092091 · Cited by 2
Direct Comparison of Urgent Transcatheter Aortic Valve Implantation and Balloon Aortic Valvuloplasty: A Systematic Review and Meta‐Analysis
Dimitriadis, K. S., Pyrpyris, N., Aznaouridis, K. A., Bonnet, G., Beneki, E., Theofilis, P., Plaites, A., Antonopoulos, A. S., Chrysohoou, C. A., & Tsioufis, K. P. (2025) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.70208 · Cited by 2
Clinical and Echocardiographic Profile of Patients With Heart Failure With Reduced Ejection Fraction: A Retrospective Outcome Analysis
Irfan, S., Padmakaran, V., Prasanth, R., Nazar, S., Srinivas, S., Tv, A. K., Bhandary, V., Patel, P. V., Baldota, R., Soman, A., et al. (2025) · Cureus · doi:10.7759/cureus.95354 · Cited by 2
“This is comparable to the European Society of Cardiology Heart Failure Long-Term Registry, where mean EF was approximately 32% and diastolic abnormalities were frequently encountered [10].”
Vericiguat in Chinese Patients with Heart Failure and Reduced Ejection Fraction: A Real-World Prospective Study
Zhou, B.-Y., Zhang, C.-Y., Zhang, Y., Ren, N., & Geng, J. (2025) · Cardiology · doi:10.1159/000549270 · Cited by 2
Association between the oxidative balance score and all-cause mortality in patients with cardiovascular disease-cancer comorbidity
Liu, F., Wang, J., Si-ao, W. E. N., Peng, S. Y., Jiang, Y. W., Liu, Z.-Y., & You, Y. (2026) · Journal of Health Population and Nutrition · doi:10.1186/s41043-025-01213-6 · Cited by 2
Prevalence and prognosis of multimorbidity in heart failure with mildly reduced ejection fraction
Reinhardt, M., Behnes, M., Abumayyaleh, M., Bertsch, T., Goertz, M., Abel, N., Schmitt, A., Lau, F., Dudda, J., Weidner, K., et al. (2026) · Clinical Research in Cardiology · doi:10.1007/s00392-025-02840-z · Cited by 2
“While arterial hypertension was the most common comorbidity in most HF studies, both in registries [39] and randomized controlled trials [35] as well as in chronic and acute HF [40], the distribution of other comorbidities varies across different studies.”
Early prediction of in-hospital mortality in ICU patients with heart failure using an interpretable machine learning model: a retrospective study based on MIMIC-IV
Sun, M., Lu, P., Cheng, J., Zhao, L., & Ma, J. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-05943-1 · Cited by 2
June 2016 at a Glance: Epidemiology, Renal Impairment, Heart Failure with Preserved Ejection Fraction
Metra, M. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.602 · Cited by 2
Self-citation
Perspetiva para a melhoria do tratamento da insuficiência cardíaca – um contributo local
Fonseca, C. (2017) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2017.05.001 · Cited by 2
Self-citation
Diabetes as a Predictor of In-Hospital and One-Year Outcomes After Decompensated Heart Failure
Fairman, E. B., Delfino, F. A., Mauro, V. M., Charask, A. A., Costa, Y. C., Raffaeli, A., Rojo, L., Rowain, V. R., Cáceres, L., & Barrero, C. (2020) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2020.100579 · Cited by 2
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Translation of the document prepared by the Czech Society of Cardiology
Táborský, M., Kautzner, J., Fedorco, M., Čurila, K., Wünschová, H., Pyszko, J., Novák, M., Kozák, M., Válek, M., Polášek, R., et al. (2022) · Cor et Vasa · doi:10.33678/cor.2022.024 · Cited by 4
Effects of renal denervation therapy on cardiac function and malignant arrhythmia in patients with reduced left ventricular ejection fraction and narrow QRS complexes treated with implantable cardioverter defibrillator
Yang, W., Xu, Y.-L., Gao, J., Shen, D., Li, M., Fa, J., Zhang, Y., Wang, R., Hou, S.-X., Hu, W.-Y., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.938486 · Cited by 2
The effectiveness of eHealth self-management interventions in patients with chronic heart failure: Protocol for a systematic review and meta-analysis
Liu, S., Li, J., Qu, Z., Li, R., & Liu, J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268446 · Cited by 2
“It is one of the main causes of hospitalization in the elderly (the number of people hospitalized is increasing every year by more than 1 million [2]).”
Background
Evaluation of a heart failure knowledge questionnaire and its use in guiding the educational intervention
Sánchez-Ramos, J. G., Lerma-Barba, M. D., Segura-Rodríguez, D., Pardo-Cabello, A. J., Molina-Ruiz, M. T., Burillo-Gómez, F., Martínez-Huertas, S., Nieto-García, E., Giner-Escobar, P., & Escobar, E. M. (2022) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2022.07.001 · Cited by 2
Epidemiology and management of heart failure with reduced ejection fraction in a Tunisian university hospital
Drissa, M., Drissa, H., Helali, S., Oughlani, K., Farah, A., & Chebbi, M. (2023) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2018-070 · Cited by 2
Recent Advances in Translational Research for Heart Failure in Japan
Yamada, S., Ko, T., Katagiri, M., MORITA, H., & Komuro, I. (2023) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2022.11.018 · Cited by 2
Differences in clinical outcomes, health care resource utilization and costs in heart failure patients according to left ventricular ejection fraction
López‐Azor, J. C., Delgado, J. F., Vélez, J., Rodríguez, R., Solı́s, J., del Oro, M., Ortega, C., Bodes, R. S., Palacios, B., Vicent, L., et al. (2023) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2023.06.003 · Cited by 2
Heart Rate Reduction and Outcomes in Heart Failure Outpatients
Memenga, F., Rybczynski, M., Magnussen, C., Goßling, A., Kondziella, C., Becher, N., Becher, P. M., Bernadyn, J., Berisha, F., Bremer, W., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12216779 · Cited by 2
Red Cell Distribution Width Is an Independent Predictor of 1-Year Mortality in a Turkish Patient Population with Acute Decompensated Heart Failure
Yüksek, Ü. (2023) · European Journal of Therapeutics · doi:10.58600/eurjther1803 · Cited by 2
What we Claim to do and what we Really do – a Discrepancy in Heart Failure Treatment
Aßmus, B., & Sossalla, S. T. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3279 · Cited by 2
Developing and Validating of the Family Coping Scale for Patients with Chronic Heart Failure
Zhang, X., Zhou, M., Jin, X., Zhang, Y., Wei, W., Bai, Y., & Ma, F. (2024) · Psychology Research and Behavior Management · doi:10.2147/prbm.s479202 · Cited by 3
Clinical and Demographic Characteristics of Patients Hospitalized for Decompensated Heart Failure with Extremely High NT-proBNP Levels
Christodorescu, R., Brie, D. M., Brie, A. D., Nistor, S., Tîrziu, A., Angela, D., Mornoş, C., Dragan, S. R., Duda-Seiman, D., Moldovan, A. P., et al. (2024) · Diagnostics · doi:10.3390/diagnostics14222507 · Cited by 2
The ADESTE Trial: A Phase 2 Study of Enibarcimab, a Monoclonal Antibody Targeting Adrenomedullin, in Acute Heart Failure
Hartopo, A. B., Achyar, A. C., Bagaswoto, H. P., Saputra, F., Mumpuni, H., Kusumastuti, D. A., Triyono, T., Sukorini, U., Puspitasari, M., Setianto, B. Y., et al. (2025) · ESC Heart Failure · doi:10.1002/ehf2.15191 · Cited by 2
Impact of nitroglycerin‐induced vasodilation on stroke volume and diuretic response in acute heart failure: A protocol for a mechanistic trial
Lau, F. F., Caidi, N. O. E., Hristovska, A., Noory, M., Lukoschewitz, J. D., Hove, J. D., Foss, N. B., & Grand, J. (2025) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.14575 · Cited by 2
Eplerenone, diabetes, and chronic kidney disease in patients hospitalized for acute heart failure: findings from the EARLIER trial
Kobayashi, M., Yamashina, A., Satomi, K., Watanabe, M., Takagi, R., Tezuka, A., Ito, S., Asakura, M., & Kitakaze, M. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02659-y · Cited by 3
“However, registry data showed that MRA therapy was often underutilized in HFrEF [7, 8], particularly for patients with both diabetes and CKD.”
Prognostic Impact of Sustained Reduction of N-Terminal Pro-B-Type Natriuretic Peptide After Initiating Sacubitril/Valsartan ― Insights From the REVIEW-HF Registry ―
Takigami, Y., Ishii, S., Iida, Y., Ikeda, Y., Nabeta, T., Oikawa, J., Nasu, T., Kanaoka, K., Kagiyama, N., Kida, K., et al. (2025) · Circulation Reports · doi:10.1253/circrep.cr-25-0029 · Cited by 2
Prognostic Value of Right Atrial Analysis in Patients With Nonischemic Cardiomyopathy
Lozano-Torres, J., Ródenas‐Alesina, E., Tobías-Castillo, P. E., Badia-Molins, C., Vila‐Olives, R., Calvo‐Barceló, M., Casas, G., Soriano-Colomé, T., Olivella, A., Sao‐Avilés, A., et al. (2025) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2025.06.012 · Cited by 2
Acute breathlessness as a cause of hospitalisation in Malawi: a prospective, patient-centred study to evaluate causes and outcomes
Spencer, S. A., Malowa, F., McCarty, D., Joekes, E. C., Phulusa, J., Chinoko, B., Kaimba, S., Keyala, L., Mandala, P., Mkandawire, M., et al. (2025) · Thorax · doi:10.1136/thorax-2025-223623 · Cited by 3
“31 Similarly, pneumonia-related mortality in our study (52% at 1 year) aligns with empirical regional observations 32 and is 50% higher than reports from the USA (31%), despite patients being on average 20 years younger (48 years vs 68 years).”
Influential
Análisis comparativo del manejo de la insuficiencia cardiaca en 2 medios diferentes: rural versus urbano. (Estudio ALBAPIC)
López, P. J. T., Perez-Romero, F. J. L., Royo, J. M. P., García, M. Á. S., Inarejos, M. J. V., Marcos, F. M., Sadek, I. M., Sánchez, R. O., & Monzo, F. P. (2020) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2020.01.003 · Cited by 2
Baseline characteristics of outpatients with heart failure according to phenotype: preliminary analysis from SMYRNA-HF registry
Şentürk, B., Çelik, A., Bekar, L., Uyan, U., Tülüce, S. Y., Güneş, H., Kerkütlüoğlu, M., Çoner, A., Kılıçaslan, B., Çetin, N., et al. (2022) · The European Research Journal · doi:10.18621/eurj.1049360 · Cited by 2
Fifteen-Year Differences in Indications for Cardiac Resynchronization Therapy in International Guidelines—Insights from the Heart Failure Registries of the European Society of Cardiology
Tymińska, A., Ozierański, K., Brociek, E., Kapłon‐Cieślicka, A., Balsam, P., Marchel, M., Crespo‐Leiro, M. G., Maggioni, A. P., Dróżdż, J., Opolski, G., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113236 · Cited by 3
Self-citation
Rationale and Design of a Prospective, Multicenter, Observational Study Evaluating Iron Deficiency in Patients Hospitalized for Heart Failure (FERIC-RO)
Antohi, E., Chitoiu, G. T., Ambrosy, A. P., Coman, I. M., Vinereanu, D., Collins, S. P., Sinescu, C. J., Mihaileanu, S., Pang, P. S., Butler, J., et al. (2018) · Revista română de medicină de laborator · doi:10.2478/rrlm-2018-0022 · Cited by 2
Self-citation
Clinical characteristics and treatment of outpatients with chronic heart failure in the Moscow Region
Константиновна, Ч. Т., & Глезер, М. Г. (2021) · Almanac of Clinical Medicine · doi:10.18786/2072-0505-2021-49-023 · Cited by 2
Levosimendan in Europe and China: An Appraisal of Evidence and Context
Kong, X., Hu, X., Hua, B., Fedele, F., Farmakis, D. T., & Pollesello, P. (2021) · European Cardiology Review · doi:10.15420/ecr.2021.41 · Cited by 2
Is the last before-death alert remote monitoring transmission in patients with heart failure life-threatening?
Dyrbuś, M., Tajstra, M., Kurek, A., Pyka, Ł., & Gąsior, M. (2022) · Kardiologia Polska · doi:10.33963/kp.a2022.0016 · Cited by 2
Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction
Raschi, E., Diemberger, I., Sabatino, M., Poluzzi, E., Ponti, F. D., & Potena, L. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2027909 · Cited by 2
Gut microbiome in heart failure and aortic stenosis
Fülöp, P., Dvorožňáková, M., Vachalcová, M., Fülöpová, Z., Šoltýs, K., & Valočík, G. (2022) · Vnitřní lékařství · doi:10.36290/vnl.2022.026 · Cited by 2
Efficacy of pharmacologic therapies in patients with acute heart failure: A network meta-analysis
Dai, H., Li, H., Wang, B., Zhang, J., Chen, Y., Zhang, X., Liu, Y., & Shang, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.677589 · Cited by 2
“, 2014), and the readmission rate may reach 50% within 4–6 months (Crespo-Leiro et al., 2016).”
Background
Safety and feasibility of angiotensin receptor neprilysin inhibitor in real-world patients with acute decompensated heart failure
Rossini, R., Angelini, F., Giordana, F., COPPINI, L., Ferraro, I., Ruffino, E., Varbella, F., Tizzani, E., Valente, E., & Musumeci, G. (2023) · Minerva Cardiology and Angiology · doi:10.23736/s2724-5683.22.06182-8 · Cited by 2
J-ACCESS investigation and nuclear cardiology in Japan: implications for heart failure
Nakajima, K., & Nishimura, T. (2023) · Annals of Nuclear Medicine · doi:10.1007/s12149-023-01836-x · Cited by 2
Clinical and prognostic implications of hyaluronic acid in hospitalized patients with heart failure
Maeda, D., Matsue, Y., Dotare, T., Sunayama, T., Iso, T., Yatsu, S., Ishiwata, S., Nakamura, Y., Akama, Y., Tsujimura, Y., et al. (2023) · Heart and Vessels · doi:10.1007/s00380-023-02269-2 · Cited by 2
L-Type Ca2+ Channels and Cardiac Arrhythmias
Kuzmenkina, E. V., Salamon, S., Despang, P., & Matthes, J. (2023) · Springer eBooks · doi:10.1007/978-3-031-33588-4_10 · Cited by 2
GECİKMİŞ POSTİNFARKT DÖVRDƏ ÜRƏYİN REMODELLƏŞMƏSİNİN XÜSUSİYYƏTLƏRİ
Abdullaiev, R. Y., Капустник, В. А., Markovsky, V. D., Куликова, Ф. И., Kyrychenko, A. G., & Tomakh, N. V. (2023) · Azerbajdžanskij medicinskij žurnal · doi:10.34921/amj.2023.3.002 · Cited by 2
The Respiratory Rate, Age, and Mean Arterial Pressure (RAM) Index: A Novel Prognostic Tool to Predict Mortality among Adult Patients with Acute Heart Failure in the Emergency Department
Chang, Y., Peng, C.-H., Chen, J.-H., Lee, Y.-T., Wu, M., & Chung, J.-Y. (2024) · Medicina · doi:10.3390/medicina60091423 · Cited by 2
Mortalidad y reingresos por insuficiencia cardiaca: la necesidad de un registro oficial completo, abierto y homologable
Lupón, J., & Bayés‐Genís, A. (2019) · Revista Española de Cardiología · doi:10.1016/j.recesp.2019.05.003 · Cited by 2
Heart failure hospitalization: Just a piece in the puzzle
Andrade, A. (2019) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2020.01.001 · Cited by 2
When Making Your Bed Feels Like Running a Marathon
Wolsk, E., & Gustafsson, F. (2020) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.007993 · Cited by 2
Cardiac rehabilitation programs for heart failure patients in the time of COVID-19
Schmidt, C., Magalhães, S., Barreira, A., Ribeiro, F., Fernandes, P., & Santos, M. (2020) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2020.11.006 · Cited by 2
Clinical Features, Socioeconomic Status, Management, and Outcomes of Acute Heart Failure: PEACE MENA Registry Phase I Results
Albackr, H. B., AlHabib, K. F., Sulaiman, K., Jamee, A., Sobhy, M. A., Benkhedda, S., Dada, S., Hammoudeh, A. J., Gamra, H., Al‐Motarreb, A., et al. (2023) · Current Vascular Pharmacology · doi:10.2174/1570161121666230525111259 · Cited by 1
Are Hospital Admissions (Costs) and Mortality Rate Impacted by Guideline-driven Treatment of Heart Failure?: A Comparison between Participants in the “CorBene” CMP and Standard-care Patients on the Basis of Propensity Score Matching
Ehling, J., Noblé, H., Gysan, D. B., Möller, M., Goss, F., Haerer, W., Glück, S., & Bansmann, P. M. (2024) · International Journal of Angiology · doi:10.1055/s-0044-1779660 · Cited by 1
4-h mean lactate clearance as a good predictor of adverse outcome in acute cardiogenic pulmonary edema: a pilot study
Vural, A., Karapehlivan, M., Dolanbay, T., Cumaoğlu, M. O., Hatip, A. Y., Çetinkaya, Y., & Ünalan, A. (2024) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2023-0255 · Cited by 1
Implementation of Guidelines in Heart Failure: Problems and Potential Solutions
Michel Komajda, N. (2024) · Journal of Asian Pacific Society of Cardiology · doi:10.15420/japsc.2024.08 · Cited by 1

Authors: Crespo-Leiro, M. G., Anker, S. D., Maggioni, A. P., Coats, A. J., Filippatos, G., Ruschitzka, F., Ferrari, R., Piepoli, M. F., Delgado Jimenez, J. F., Metra, M., Fonseca, C., Hradec, J., Amir, O., Logeart, D., Dahlström, U., Merkely, B., Drozdz, J., Goncalvesova, E., Hassanein, M., Chioncel, O., Lainscak, M., Seferovic, P. M., Tousoulis, D., Kavoliuniene, A., Fruhwald, F., Fazlibegovic, E., Temizhan, A., Gatzov, P., Erglis, A., Laroche, C., & Mebazaa, A.
Affiliations: Unidad de Insuficiencia Cardiaca Avanzada y Trasplante Cardiaco, Complexo Hospitalario Universitario A Coruna, CHUAC , La Coruna ,
Universitätsmedizin Göttingen (DE)
European Society of Cardiology (FR)
University of Warwick (GB)
University General Hospital Attikon (GR)
University of Zurich (CH)
University of Ferrara (IT)
Azienda Unità Sanitaria Locale Piacenza (IT)
Cardiology Department, University Hospital 12 de Octubre , Madrid ,
University of Brescia (IT)
Heart Failure Unit, S Francisco Xavier Hospital/CHLO NOVA Medical School, Faculdade de Ciências Medicas, Universidade Nova de Lisboa
Charles University (CZ)
Bar-Ilan University (IL)
Inserm (FR)
Linköping University (SE)
Semmelweis University, Heart Centre , Budapest ,
Department of Cardiology, Medical University of Lodz , Lodz ,
Department of Heart Failure/Transplantation, National Cardiovascular Institute , Bratislava ,
Alexandria University (EG)
Carol Davila University of Medicine and Pharmacy (RO)
Department of Cardiology, General Hospital Celje , Celje ,
University of Belgrade (RS)
National and Kapodistrian University of Athens (GR)
Department of Cardiology, Lithuanian University of Health Sciences , Kaunas ,
Medical University of Graz (AT)
Department of Internal Medicine, Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina
Türkiye Yüksek İhtisas Hastanesi (TR)
Lozenetz Hospital (BG)
Pauls Stradins Clinical University Hospital , Riga ,
ORCID: Anker, Stefan D.
Maggioni, Aldo P.
Coats, Andrew J.
Filippatos, Gerasimos
Ruschitzka, Frank
Ferrari, Roberto
Piepoli, Massimo Francesco
Metra, Marco
Hradec, Jaromir
Logeart, Damien
Dahlström, Ulf
Hassanein, Mahmoud
Chioncel, Ovidiu
Seferovic, Petar M.
Tousoulis, Dimitris
Temizhan, Ahmet
Mebazaa, Alexandre
Venue: European Journal of Heart Failure
Publisher: Oxford University Press (OUP)
Published: 2016-06-01
Volume: 18
Issue: 6
Pages: 613-625
ISSN: 1388-9842 (ISSN-L)
1879-0844
DOI: 10.1002/ejhf.566
OpenAlex: W2465883722
Cited by: 798
References: 26
Citations by year: 2026: 54 · 2025: 88 · 2024: 88 · 2023: 108 · 2022: 97 · 2021: 79 · 2020: 92 · 2019: 61 · 2018: 65 · 2017: 52 · 2016: 13
FWCI: 52.52
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: academic.oup.com/pages/standard-publication-reuse-rights (vor)
Locations: European Journal of Heart Failure (publishedVersion)
PubMed (publishedVersion)
LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (acceptedVersion)
Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
Monash University Research Portal (Monash University) (submittedVersion, other-oa)
Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
Lithuanian University of Health Sciences (submittedVersion)
RUC (Universidade Da Coruña) (submittedVersion)
Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion, other-oa)
Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
Funders: ESC.
Abbott Vascular International (2011-2014)
Amgen (2012-2015)
AstraZeneca (2014-2017)
Bayer (2013-2018)
Boehringer Ingelheim (2013-2016)
Boston Scientific (2010-2012)
The Bristol Myers Squibb
Pfizer Alliance (2014-2016)
The Alliance Daiichi Sankyo Europe GmbH
Eli Lilly and Company (2014-2017)
Gedeon Richter Plc. (2014-2017)
Menarini Int. Op. (2010-2012)
MSD-Merck and Co. (2011-2014)
Novartis Pharma AG (2014-2017)
ResMed (2014-2016)
Sanofi (2010-2011)
SERVIER (2012-2015)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
Keywords: heart failure, acute heart failure, chronic heart failure, all-cause mortality, one-year outcomes, heart failure hospitalization, regional variation in mortality, clinical epidemiology
MeSH terms: Acute Disease, Aged, Aged, 80 and over, Ambulatory Care, Cardiology, Cause of Death, Chronic Disease, Europe, Female, Follow-Up Studies, Heart Failure, Hospitalization, Humans, Male, Middle Aged, Mortality, Prospective Studies, Registries, Societies, Medical, Comorbidity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-Year Follow-Up Outcomes and Differences Across Regions

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks